Corient Private Wealth LLC Buys 10,226 Shares of GE HealthCare Technologies Inc. $GEHC

Corient Private Wealth LLC increased its stake in GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 18.7% in the 4th quarter, according to its most recent disclosure with the SEC. The institutional investor owned 65,023 shares of the company’s stock after acquiring an additional 10,226 shares during the period. Corient Private Wealth LLC’s holdings in GE HealthCare Technologies were worth $5,309,000 as of its most recent SEC filing.

Other institutional investors also recently made changes to their positions in the company. Vanguard Group Inc. grew its position in GE HealthCare Technologies by 0.5% during the 4th quarter. Vanguard Group Inc. now owns 52,275,767 shares of the company’s stock worth $4,287,658,000 after acquiring an additional 267,058 shares during the last quarter. Auto Owners Insurance Co lifted its holdings in GE HealthCare Technologies by 9,525.4% in the fourth quarter. Auto Owners Insurance Co now owns 33,982,610 shares of the company’s stock worth $278,725,000 after buying an additional 33,629,559 shares during the period. Dodge & Cox boosted its holdings in shares of GE HealthCare Technologies by 13.4% during the 4th quarter. Dodge & Cox now owns 31,211,229 shares of the company’s stock valued at $2,559,945,000 after buying an additional 3,693,918 shares in the last quarter. Capital Research Global Investors increased its stake in shares of GE HealthCare Technologies by 1.6% during the fourth quarter. Capital Research Global Investors now owns 25,362,352 shares of the company’s stock valued at $2,080,248,000 after purchasing an additional 389,796 shares in the last quarter. Finally, State Street Corp raised its stake in GE HealthCare Technologies by 2.0% during the fourth quarter. State Street Corp now owns 20,049,677 shares of the company’s stock valued at $1,644,475,000 after buying an additional 401,932 shares during the last quarter. Hedge funds and other institutional investors own 82.06% of the company’s stock.

Wall Street Analyst Weigh In

A number of equities analysts recently weighed in on GEHC shares. HSBC decreased their price objective on shares of GE HealthCare Technologies from $100.00 to $90.00 in a report on Thursday, April 30th. Jefferies Financial Group reduced their price objective on GE HealthCare Technologies from $105.00 to $90.00 in a research note on Thursday, April 30th. BTIG Research lowered their price target on shares of GE HealthCare Technologies from $85.00 to $80.00 and set a “buy” rating on the stock in a report on Wednesday, April 29th. Evercore set a $80.00 price target on GE HealthCare Technologies in a report on Thursday, April 30th. Finally, Argus cut their price objective on GE HealthCare Technologies from $95.00 to $80.00 and set a “buy” rating for the company in a research report on Tuesday, May 19th. Ten analysts have rated the stock with a Buy rating and nine have given a Hold rating to the stock. According to MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and a consensus target price of $80.20.

GE HealthCare Technologies Stock Performance

Shares of GE HealthCare Technologies stock opened at $65.76 on Friday. The firm has a market capitalization of $29.91 billion, a P/E ratio of 15.73, a PEG ratio of 1.77 and a beta of 0.74. The company has a quick ratio of 0.95, a current ratio of 1.22 and a debt-to-equity ratio of 0.95. GE HealthCare Technologies Inc. has a 52 week low of $58.75 and a 52 week high of $89.77. The company has a 50 day moving average price of $64.51 and a 200 day moving average price of $73.96.

GE HealthCare Technologies (NASDAQ:GEHC) last issued its earnings results on Wednesday, April 29th. The company reported $0.99 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $1.07 by ($0.08). GE HealthCare Technologies had a return on equity of 20.46% and a net margin of 9.10%.The firm had revenue of $5.13 billion during the quarter, compared to analysts’ expectations of $5.04 billion. During the same quarter last year, the business earned $1.01 EPS. The business’s revenue was up 7.4% on a year-over-year basis. GE HealthCare Technologies has set its FY 2026 guidance at 4.800-5.000 EPS. Sell-side analysts expect that GE HealthCare Technologies Inc. will post 4.89 EPS for the current year.

Insider Transactions at GE HealthCare Technologies

In related news, Director Kevin Lobo purchased 10,000 shares of GE HealthCare Technologies stock in a transaction that occurred on Friday, May 22nd. The stock was bought at an average cost of $64.18 per share, for a total transaction of $641,800.00. Following the completion of the transaction, the director owned 14,363 shares in the company, valued at $921,817.34. The trade was a 229.20% increase in their ownership of the stock. The acquisition was disclosed in a document filed with the SEC, which is accessible through this link. Also, Director Rodney F. Hochman bought 1,618 shares of the business’s stock in a transaction dated Tuesday, May 12th. The shares were purchased at an average cost of $62.03 per share, with a total value of $100,364.54. Following the completion of the acquisition, the director owned 1,618 shares in the company, valued at approximately $100,364.54. This represents a ∞ increase in their ownership of the stock. The SEC filing for this purchase provides additional information. Over the last ninety days, insiders have bought 21,847 shares of company stock valued at $1,361,355. 0.36% of the stock is owned by insiders.

GE HealthCare Technologies Profile

GE HealthCare Technologies (NASDAQ: GEHC) is a global medical technology and diagnostics company that develops, manufactures and markets a broad range of products and services for healthcare providers. Its portfolio centers on diagnostic imaging systems, including MRI, CT, PET and X-ray modalities, as well as ultrasound equipment. The company also supplies patient monitoring and anesthesia delivery systems, interventional and surgical imaging solutions, and molecular imaging technologies used in both clinical care and research settings.

In addition to hardware, GE HealthCare offers software, analytics and lifecycle services aimed at improving clinical workflows and equipment uptime.